Summary
GlobalData, the industry analysis specialist's new report, "Allergic Rhinitis-Drug Pipeline Analysis and Market Forecasts to 2016" is an essential source of information and analysis on the global allergic rhinitis market. The report identifies the key trends shaping and driving the global allergic rhinitis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global allergic rhinitis sector.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData's team of industry experts.

Scope
The scope of the report includes:
-Annualized global allergic rhinitis market revenues data from 2000 to 2009, forecast forward for 7 years to 2016.
-Geographic markets covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
-Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends.
-Analysis of the current and future market competition in the global allergic rhinitis market.
-Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
-Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with allergic rhinitis.

Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
-Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
-Develop business strategies by understanding the trends shaping and driving the global allergic rhinitis market.
-Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global allergic rhinitis market in future.
-Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
-Identify emerging players with potentially strong product portfolio and create effective   counter-strategies to gain competitive advantage.
-Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
-What's the next big thing in the global allergic rhinitis market landscape? -Identify, understand and capitalize.

Table of Contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Global Allergic Rhinitis: Market Characterization 5
2.1 Overview 5
2.2 Allergic Rhinitis Market Size 5
2.3 Allergic Rhinitis Market Forecast and Compounded Annual Growth Rate 6
2.4 Drivers and Barriers for the Allergic Rhinitis Market 6
2.4.1 Drivers for the Allergic Rhinitis Market 7
2.4.2 Barriers for the Allergic Rhinitis Market 7
2.5 Opportunity and Unmet Need 7
2.6 Key Takeaway 8
3 Global Allergic Rhinitis Market: Competitive Assessment 10
3.1 Overview 10
3.2 Strategic Competitor Assessment 10
3.3 Product Profile for the Major Marketed Products in the Allergic Rhinitis Market 11
3.3.1 Nasacort AQ (triamcinolone acetonide) 11
3.3.2 Astelin (azelastine hydrochloride) 12
3.3.3 Nasonex (mometasone furoate monohydrate) 13
3.3.4 Singulair (Montelukast Sodium) 15
3.3.5 Rhinocort Aqua (budesonide) 17
3.3.6 Veramyst (fluticasone furoate) 19
3.3.7 Xyzal (levocetirizine dihydrochloride) 20
3.4 Key Takeaway 22
4 Global Allergic Rhinitis Market: Pipeline Assessment 23
4.1 Overview 23
4.2 Strategic Pipeline Assessment 23
4.3 Allergic Rhinitis Market-Promising Drugs under Clinical Development 25
4.4 Molecule Profile for Promising Drugs under Clinical Development 25
4.4.1 Bilastine 25
4.4.2 Sublivac (Extracts of allergens) 26
4.4.3 Duonase (Azelastine+ Fluticasone) 26
4.4.4 GSK256066 (MDX-010, MDX-101) 27
4.5 Allergic Rhinitis Market-Clinical Pipeline by Mechanism of Action 28
4.5.1 Allergic Rhinitis-Phase III Clinical Pipeline 29
4.5.2 Allergic Rhinitis-Phase II Clinical Pipeline 30
4.5.3 Allergic Rhinitis-Phase I Clinical Pipeline 31
4.5.4 Allergic Rhinitis-Preclinical Pipeline 31
4.5.5 Allergic Rhinitis-List of Terminated Clinical Trials 31
4.6 Key Take Away 32
5 Global Allergic Rhinitis Market: Implications for Future Market Competition 33
6 Global Allergic Rhinitis Market: Future Players 34
6.1 Introduction 34
6.2 GlaxoSmithKline 34
6.2.1 Company Overview 34
6.2.2 Business Description 35
6.3 Sanofi-Aventis 35
6.3.1 Company Overview 35
6.4 Novartis 37
6.4.1 Company Overview 37
6.4.2 Business Description 37
6.5 AstraZeneca 38
6.5.1 Overview 38
6.5.2 Business Description 38
6.6 Merck & Co 39
6.6.1 Overview 39
6.6.2 Business Description 40
7 Allergic Rhinitis Market: Appendix 41
7.1 Definitions 41
7.2 Acronyms 41
7.3 Research Methodology 42
7.3.1 Coverage 42
7.3.2 Secondary Research 43
7.3.3 Forecasting 43
7.3.4 Primary Research 46
7.3.5 Expert Panels 46
7.4 Contact Us 46
7.5 Disclaimer 46
7.6 Sources 47

List of Tables
1.1 List of Tables
Table 1:  Allergic Rhinitis Market, Global, Historical Revenue ($ bn), 2001-2009 6
Table 2:  Allergic Rhinitis Market, Global, Forecasted Reveune ($ bn), 2010-2016 6
Table 3:  Major Marketed Products Comparison in Allergic Rhinitis Market, 2010 22
Table 4:  Allergic Rhinitis Therapeutics-Most Promising Drugs Under Clinical Development, 2010 25
Table 5:   Allergic Rhinitis Therapeutics-Phase III Clinical Pipeline, 2010 29
Table 6: Allergic Rhinitis Therapeutics-Phase II Clinical Pipeline, 2010 30
Table 7:  Allergic Rhinitis Therapeutics-Phase I Clinical Pipeline, 2010 31
Table 8: Allergic Rhinitis Therapeutics-Preclinical Pipeline, 2010 31
Table 9:  Allergic Rhinitis Therapeutics-List of Terminated Clinical Trials, 2010 31
Table 10:  GlaxoSmithKline plc, Reparatory Disease Product Portfolio, 2010 35
Table 11:  Sanofi-Aventis, Reparatory Disease Product Portfolio, 2010 36
Table 12:  Novartis AG, Reparatory Disease Product Portfolio, 2010 38
Table 13:  AstraZeneca PLC, Reparatory Disease Product Portfolio, 2010 39
Table 14:  Merck & Co., Inc, Reparatory Disease Product Portfolio, 2010 40

List of Figures
1.2 List of Figures
Figure 1:  Allergic Rhinitis Market, Global, Revenue Forecast ($ bn), 2001-2016 6
Figure 2:  Opportunity and Unmet Need in the Allergic Rhinitis Market, 2010 8
Figure 3:  Strategic Competitor Assessment, 2010 10
Figure 4:  Pipeline Products by Phase of Development, 2010 23
Figure 5:  Technology Trends Analytics Frame Work, 2010 24
Figure 6:  Technology Trends Analytics Frame Work-Description, 2010 24
Figure 7:  Allergic Rhinitis Market-Clinical Pipeline by Mechanism of Action, 2010 28
Figure 8:  Allergic Rhinitis Market-Clinical Pipeline by Phase of Development, 2010 28
Figure 9:  Implications for Future Market Competition in the Allergic Rhinitis Market, 2010 33
Figure 10:  Allergic Rhinitis Therapeutics Market-Clinical Pipeline by Company, 2010 34
Figure 11:  GlobalData Methodology 42
Figure 12:  GlobalData Market Forecasting Model 45